Hope Medicine
PrivateLast Round
Series B
Extension
Feb 8, 2024
Total Funding Raised
$84.1M
Company Overview
Hope Medicine operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Series B Extension round in February 2024.
Hope Medicine is a biopharmaceutical company that develops and commercializes medicines for endocrine, cardiovascular, and metabolic diseases, with a special focus on women's health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hope Medicine Comparables
Compare Hope Medicine with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gesynta Pharma AB | 78% | |
| EndoCyclic Therapeutics | 74% | |
| Organon & Co. | 74% |
For institutional investors. Book with your work email.
Hope Medicine Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Feb 8, 2024 | ||||
| Series B | May 6, 2021 | ||||
| Series A | Apr 8, 2019 |
For institutional investors. Book with your work email.
Hope Medicine Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| HighLight Capital | Series B |
| VMS Asset Management | Series B Extension |
| Sinovation Ventures | Series B Extension, Series B |
| Wuxi Capital Group Co.,Ltd | Series B Extension |
| Trustbridge Partners | Series B Extension, Series B, Series A |
| Ennovation Ventures | Series B Extension |
| Qiming Venture Partners | Series B Extension, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 8, 2024
$28.1M round led by VMS Asset Management and Wuxi Capital Group.
- May 6, 2021
$56M round led by Grand Flight Investment and Qiming Venture Partners.
For institutional investors. Book with your work email.
Hope Medicine Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hope Medicine's valuation, stock price, and market status.
Is Hope Medicine a public or private company?
Hope Medicine is a private company.
What is the current stock price of Hope Medicine?
Hope Medicine is a private company, so its shares have no public market price. Caplight tracks Hope Medicine's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hope Medicine worth (valuation)?
Valuation information for Hope Medicine is not publicly available.
Can I buy Hope Medicine stock?
Hope Medicine shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hope Medicine's last funding round?
Hope Medicine's most recent funding round was Series B Extension on February 8, 2024.
Who are the main investors in Hope Medicine?
Key investors in Hope Medicine include VMS Asset Management, Wuxi Capital Group Co.,Ltd, Qiming Venture Partners, Grand Flight Investment.
Will Hope Medicine IPO soon?
No public IPO plans have been announced for Hope Medicine.
How can I track Hope Medicine secondary market activity?
Caplight tracks bids, offers, and trades in Hope Medicine's shares on secondary markets.